Cardiovascular Disease Doctors in Anniston, AL Accepting Medicare

4 Cardiovascular Disease doctors found. Showing 1 - 4

Mohamed Jasser, MD Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 901 Leighton Ave, Suite 307, Anniston, AL 36207 Phone: 256-231-8636    Fax: 256-231-8684

Dr. Mohammad Kamran, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 1700 Christine Ave, Ste 100, Anniston, AL 36207 Phone: 256-238-1154    Fax: 256-237-8624

Judy R. Washington, CRNP Internal Medicine - Cardiovascular Disease Medicare: Medicare Enrolled Practice Location: 171 Town Center Dr, Anniston, AL 36205 Phone: 256-237-1624    Fax: 256-241-2277

Dr. John I Nwogu, M.D. Internal Medicine - Cardiovascular Disease Medicare: Accepting Medicare Assignments Practice Location: 901 Leighton Ave Ste 702, Anniston, AL 36207 Phone: 256-231-2577    Fax: 256-231-2576

News Archive

Engineers develop prototype telerobotic platform for bladder cancer treatment

Although bladder cancer is the sixth most common form of cancer in the U.S. and the most expensive to treat, the basic method that doctors use to treat it hasn't changed much in more than 70 years.

Enrollment commences in Allos' FOLOTYN Phase 3 trial for peripheral T-cell lymphoma

Allos Therapeutics, Inc. today announced the enrollment of the first patient in a Phase 3 randomized clinical trial (PDX-017) evaluating FOLOTYN in patients with previously undiagnosed peripheral T-cell lymphoma.

NetApp, Stanford Genome Technology Center build gastric cancer registry powered by NetApp storage technology

Gastric cancer is the number two cancer killer worldwide and one of the top cancer killers in the U.S., but gastric cancer research gets the least federal funding of any type of cancer research. According to a CBS News analysis of data released by the American Cancer Society, for every cancer-related death in the U.S., only $1,168 federal research dollars are spent on gastric cancer, versus $18,870 for cancer of the cervix and $14,095 for breast cancer.

PharmaVentures acts as advisor and broker to Dr Reddy's in distribution agreement with Vitabiotics

PharmaVentures Ltd announced today that it had acted as the advisor and broker to the Indian pharmaceutical company Dr Reddy's Laboratories in its successful marketing and distribution agreement with the UK healthcare company Vitabiotics Ltd for a range of nutraceutical products. The agreement provides Dr Reddy's exclusive marketing rights in the Russian/CIS markets for two of Vitabiotics' leading products - Jointace and Dietrim. Vitabiotics will supply these products on a long-term basis from its facilities in Europe.

Read more Medical News

› Verified 2 days ago